Discontinued — last reported Q3 '24
Products & Services · Deferred Revenue
Oncology Assay Interpretation Services — Deferred Revenue
Natera, Inc. Oncology Assay Interpretation Services — Deferred Revenue decreased by 84.1% to $3.00M in Q3 2024 compared to the prior quarter. Year-over-year, this metric grew by 328.6%, from $700.00K to $3.00M.
Analysis
StatementSegment
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ1 2023
Last reportedQ3 2024
Rolls up toContract Liabilities
How to read this metric
An increase indicates strong upfront demand or billing activity, while a decrease may signal that the company is working through its service backlog faster than it is securing new prepayments.
Detailed definition
This metric represents the balance of obligations to customers for oncology assay interpretation services for which the...
Peer comparison
Similar to 'Deferred Revenue' or 'Contract Liabilities' reported by other healthcare service providers under standard accounting frameworks.
Metric ID:
ntra_segment_oncology_assay_interpretation_services_contract_with_customer_liabilityHistorical Data
7 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | |
|---|---|---|---|---|---|---|---|
| Value | $600.00K | $200.00K | $700.00K | $1.20M | $3.20M | $18.90M | $3.00M |
| QoQ Change | — | -66.7% | +250.0% | +71.4% | +166.7% | +490.6% | -84.1% |
| YoY Change | — | — | — | — | +433.3% | >999% | +328.6% |
Range$200.00K – $18.90M
CAGR+192.4%
Avg YoY Growth>999%
Median YoY Growth+433.3%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Natera, Inc.'s oncology assay interpretation services — deferred revenue?
- Natera, Inc. (NTRA) reported oncology assay interpretation services — deferred revenue of $3.00M in Q3 2024.
- How has Natera, Inc.'s oncology assay interpretation services — deferred revenue changed year-over-year?
- Natera, Inc.'s oncology assay interpretation services — deferred revenue increased by 328.6% year-over-year, from $700.00K to $3.00M.
- What does oncology assay interpretation services — deferred revenue mean?
- The total amount of money received or billed for oncology services that have not yet been provided to the customer.